Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.17 billion. The enterprise value is $5.27 billion.
Important Dates
The last earnings date was Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Dec 23, 2025 |
Share Statistics
Balchem has 32.03 million shares outstanding. The number of shares has decreased by -0.88% in one year.
| Current Share Class | 32.03M |
| Shares Outstanding | 32.03M |
| Shares Change (YoY) | -0.88% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 91.90% |
| Float | 31.80M |
Valuation Ratios
The trailing PE ratio is 33.16 and the forward PE ratio is 27.94. Balchem's PEG ratio is 3.10.
| PE Ratio | 33.16 |
| Forward PE | 27.94 |
| PS Ratio | 4.89 |
| Forward PS | n/a |
| PB Ratio | 4.06 |
| P/TBV Ratio | 16.31 |
| P/FCF Ratio | 29.39 |
| P/OCF Ratio | 23.50 |
| PEG Ratio | 3.10 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 20.17, with an EV/FCF ratio of 29.94.
| EV / Earnings | 33.33 |
| EV / Sales | 4.98 |
| EV / EBITDA | 20.17 |
| EV / EBIT | 24.58 |
| EV / FCF | 29.94 |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.55 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | 0.96 |
| Interest Coverage | 22.52 |
Financial Efficiency
Return on equity (ROE) is 12.68% and return on invested capital (ROIC) is 12.13%.
| Return on Equity (ROE) | 12.68% |
| Return on Assets (ROA) | 8.09% |
| Return on Invested Capital (ROIC) | 12.13% |
| Return on Capital Employed (ROCE) | 13.91% |
| Weighted Average Cost of Capital (WACC) | 8.76% |
| Revenue Per Employee | $782,064 |
| Profits Per Employee | $116,921 |
| Employee Count | 1,352 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 4.62 |
Taxes
In the past 12 months, Balchem has paid $45.54 million in taxes.
| Income Tax | 45.54M |
| Effective Tax Rate | 22.36% |
Stock Price Statistics
The stock price has increased by +3.18% in the last 52 weeks. The beta is 0.85, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +3.18% |
| 50-Day Moving Average | 172.54 |
| 200-Day Moving Average | 161.25 |
| Relative Strength Index (RSI) | 32.06 |
| Average Volume (20 Days) | 219,647 |
Short Selling Information
The latest short interest is 342,846, so 1.07% of the outstanding shares have been sold short.
| Short Interest | 342,846 |
| Short Previous Month | 380,559 |
| Short % of Shares Out | 1.07% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 1.66 |
Income Statement
In the last 12 months, Balchem had revenue of $1.06 billion and earned $158.08 million in profits. Earnings per share was $4.87.
| Revenue | 1.06B |
| Gross Profit | 383.55M |
| Operating Income | 214.34M |
| Pretax Income | 203.61M |
| Net Income | 158.08M |
| EBITDA | 261.22M |
| EBIT | 214.34M |
| Earnings Per Share (EPS) | $4.87 |
Full Income StatementBalance Sheet
The company has $72.87 million in cash and $169.00 million in debt, with a net cash position of -$96.13 million or -$3.00 per share.
| Cash & Cash Equivalents | 72.87M |
| Total Debt | 169.00M |
| Net Cash | -96.13M |
| Net Cash Per Share | -$3.00 |
| Equity (Book Value) | 1.29B |
| Book Value Per Share | 39.81 |
| Working Capital | 236.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $220.16 million and capital expenditures -$44.18 million, giving a free cash flow of $175.98 million.
| Operating Cash Flow | 220.16M |
| Capital Expenditures | -44.18M |
| Depreciation & Amortization | 46.88M |
| Net Borrowing | -21.20M |
| Free Cash Flow | 175.98M |
| FCF Per Share | $5.49 |
Full Cash Flow StatementMargins
Gross margin is 36.27%, with operating and profit margins of 20.27% and 14.95%.
| Gross Margin | 36.27% |
| Operating Margin | 20.27% |
| Pretax Margin | 19.26% |
| Profit Margin | 14.95% |
| EBITDA Margin | 24.71% |
| EBIT Margin | 20.27% |
| FCF Margin | 16.64% |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 0.59%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 0.59% |
| Dividend Growth (YoY) | 10.34% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 19.71% |
| Buyback Yield | 0.88% |
| Shareholder Yield | 1.48% |
| Earnings Yield | 3.06% |
| FCF Yield | 3.40% |
Dividend DetailsAnalyst Forecast
The average price target for Balchem is $176.00, which is 8.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $176.00 |
| Price Target Difference | 8.97% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |
